Drug Discovery
-
healthStanford's AI Agents Cut Drug Discovery Timelines from Months to Days
Stanford researchers deploy a team of specialized AI agents that compress drug discovery from months to days, generating 92 novel COVID-19 candidates and highlighting promise for biotech investors.
-
techBristol Myers Squibb Deploys Anthropic's Claude AI Across Global Operations
Bristol Myers Squibb partners with Anthropic to deploy Claude AI across 30,000 employees, accelerating drug discovery and clinical documentation.
-
healthIsomorphic Labs Raises $2.1B to Scale AI Drug Discovery
Google-backed Isomorphic Labs secures $2.1 billion in Series C funding to scale its AI-powered drug design engine and accelerate clinical trials.
-
techOpenAI's Rosalind AI Aims to Revolutionize Drug Discovery, But Access is Limited
OpenAI introduces GPT-Rosalind, a specialized AI model designed to accelerate drug discovery. However, concerns over biosecurity restrict its widespread use.
-
techOpenAI Unveils GPT-Rosalind for Life Sciences Breakthroughs
OpenAI introduces GPT-Rosalind, an AI model designed to accelerate research in biology, drug discovery, and medicine by enhancing scientific workflows and reasoning.
-
healthAmazon Unveils AI Platform to Accelerate Drug Discovery
AWS launches Amazon Bio Discovery, an AI platform designed for rapid drug and antibody discovery, streamlining research workflows for scientists without coding expertise.
-
healthAmazon Unveils AI Tool to Revolutionize Early-Stage Drug Discovery
Amazon Web Services launches Amazon Bio Discovery, an AI-powered platform designed to dramatically accelerate the identification and evaluation of potential drug molecules for pharmaceutical research.
-
techNovo Nordisk Taps OpenAI for Accelerated Drug Discovery
Novo Nordisk partners with OpenAI to leverage advanced AI, aiming to speed up drug research, improve manufacturing, and bring new treatments for obesity and diabetes to patients faster.